New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?

Nele Van Der Steen,1,* Chiara Caparello,2,* Christian Rolfo,3 Patrick Pauwels,4 Godefridus J Peters,1 Elisa Giovannetti5 1Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands; 2Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 3Phas...

Full description

Bibliographic Details
Main Authors: Van Der Steen N, Caparello C, Rolfo C, Pauwels P, Peters GJ, Giovannetti E
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:OncoTargets and Therapy
Subjects:
Rociletinib
EGFR
EGFR-TKI
NSCLC
targeted therapies
Online Access:https://www.dovepress.com/new-developments-in-the-management-of-non-small-cell-lung-cancer-focus-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/new-developments-in-the-management-of-non-small-cell-lung-cancer-focus-peer-reviewed-article-OTT

Similar Items